From Quiescence to Activation: The Reciprocal Regulation of Ras and Rho Signaling in Hepatic Stellate Cells

Area of Science:

• Cell Biology
• Hepatology
• Molecular Signaling

Background:

• Chronic liver diseases involve persistent inflammation, leading to fibrosis, cirrhosis, and cancer.
• Hepatic stellate cells (HSCs) shift from quiescent to activated states, impacting liver regeneration and disease progression.

Purpose of the Study:

• To elucidate the intracellular signaling networks governing HSC quiescence and activation.
• To identify key signaling molecules regulating HSC fate decisions in chronic liver disease.

Main Methods:

• Analysis of differential expression of Ras GTPases (Eras, Mras) and Rho GTPases (Rnd3, Rhoc) in quiescent versus activated HSCs.
• Investigation of the roles of cytosolic Notch1 and Rock signaling in HSC states.
• Development of methods to maintain HSCs in a quiescent state for mechanistic studies.

Main Results:

• Eras and Rnd3 are predominantly expressed in quiescent HSCs, while Mras and Rhoc are abundant in activated HSCs.
• Cytosolic Notch1 is critical in quiescent HSCs, and Rock signaling is key in activated HSCs.
• Distinct signaling pathways regulate HSC homeostasis and activation, influencing proliferation and cell fate.

Conclusions:

• Intracellular signaling networks dynamically regulate HSC fate, impacting chronic liver disease progression.
• Understanding these pathways offers potential for novel therapeutic strategies targeting Ras- and Rho-dependent pathways.
• Targeting specific signaling molecules could lead to innovative treatments for liver fibrosis and related conditions.